Lopixibat

solute carrier family 10 member 2 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34813049 Maralixibat: First Approval. 2022 Jan 1
2 35507739 Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study. 2022 May 4 1
3 32653991 Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders. 2020 Sep 1